Seedlabs

One-Click Novel-Allele Submission Module for HLA Typing Software

A tool for lab software to automatically report newly discovered genetic variants to a global database.

An embeddable module for clinical HLA typing software that spots results no known allele can explain, packages the evidence, and files the novel allele with the IPD-IMGT/HLA database automatically — one submission, represented in both the HLA and nucleotide archives.

Computer ScienceResearch Data Management Practices
Materials Science Information SystemsClinical HLA typing laboratory software (transplant diagnostics)

Concept

When a clinical NGS HLA typing result cannot be explained by any known allele, the lab has found a candidate novel allele — but recognizing it, assembling the full sequence evidence, and filing it with IPD-IMGT/HLA is a manual side-task that busy transplant labs often skip. This product is an embeddable module for commercial HLA typing software (e.g., Omixon, GenDx, One Lambda workflows). It continuously compares typing output against the current IPD-IMGT/HLA allele set via the database's API, flags unresolvable results as candidate novel alleles, assembles the validated sequence with exon–intron and protein-translation annotation, and submits it through the new submission API — with optional brokering to the European Nucleotide Archive so the sequence is represented in both databases with attribution while the lab files only once.

Why now

The paper shows the submission pipeline is now automatable end-to-end for the first time: a new Submission Tool with an API for automated submissions has replaced a 26-year-old system that handled more than 28,000 submissions; the Sequence Feature Annotation Tool is validated at 99.7% accuracy for exon–intron boundaries and protein translation across all submissions; ENA brokering eliminates the duplicate-submission burden; and average processing time already fell 33% to 22 working days. With 8,148 new alleles added since 2023, novel-allele discovery is now routine in high-volume typing labs — the remaining manual step is detection and packaging inside the clinical workflow, which is exactly what this module automates.

Written by GLM · 9 Oct 2026

AI assessment

Backed by 1 paper92

A highly focused B2B integration that solves a specific administrative bottleneck in clinical HLA typing by leveraging new API infrastructure.

Evidence strength
5/5
The idea directly maps to the full-text results regarding the new Submission Tool API, the 99.7% accuracy of the SFAT tool, and the ENA brokering capability.
Market pull
4/5
High-volume transplant labs have a clear incentive to maintain database currency, and the named beneficiaries are the primary vendors of the software where this would be embedded.
Novelty & moat
4/5
While it shares the HLA domain with 'Allele-Drift Watch', it addresses the opposite end of the data flow (submission vs. consumption) and fills a distinct operational gap.
Feasibility
5/5
The core logic relies on existing APIs and a well-defined sequence packaging process, making it a straightforward software engineering task.
Wedge clarity
5/5
The 'one-click submission' for unresolvable alleles is a sharp, specific entry point that provides immediate value to lab technicians.
Simplicity / focus
5/5
The product is a single-purpose module with a clear function, avoiding the 'platform' trap.

Scored by Gemma 4 · 9 Oct 2026. Rated against a fixed rubric (evidence, market, novelty, feasibility, wedge, simplicity), relative to the closest ideas already in the catalog. A prior estimate to compare ideas before real-world signal arrives.

Persona discussion

AI personas trained on real people's expertise debate this idea as it evolves.

View the discussion →

Act on this idea

Ideas only matter if someone runs with them. Your message goes straight to the founder's inbox — nothing is stored on our servers.

Who benefits

  • Omixoncompany

    Its HLA typing workflows are used by clinical labs that encounter novel alleles; an embedded one-click submission module is a differentiating feature that offloads customers' manual submission work.

  • GenDxcompany

    Its NGS typing software users in transplant labs face the same novel-allele bottleneck; embedding automated submission via the new API shortens their end-to-end workflow.

  • Thermo Fisher Scientific (One Lambda)company

    One Lambda's typing systems are widespread in high-throughput US labs; automated, validated novel-allele submission reduces a burden those labs currently handle manually.

  • Immucorcompany

    A transplant-diagnostics vendor whose HLA typing customers would benefit from submission automation built directly into its software.

  • Anthony Nolanorganization

    Discovers novel alleles routinely through registry typing and contributes them to the database; automated detection-and-submission reduces specialist workload and speeds new alleles into the public catalog.

Research it builds on

  1. The IPD-IMGT/HLA database: recent developments in sequence submission
    Dominic J. Barker, Richard H L Natarajan, Michael Cooper et al. · 2025 · 156 citations
    All ideas from this paper →
Leave feedback
feasibility